Clinical and parasitological responses after up to 6.5 years of ivermectin treatment for onchocerciasis

Tropical Medicine and International Health

Volumn 1, Issue 6, 1996, Pages 786-793

  Whitworth, J A G ^a,c   Maude, G H ^a   Downham, M D ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Medical Research Centre   (Sierra Leone)

^c UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

Author keywords

itching; ivermectin; microfilaridermia; onchocerciasis; Sierra Leone; skin disease

Indexed keywords

IVERMECTIN; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCHOCERCIASIS; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREVALENCE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SIERRA LEONE; SKIN DISEASE;

PANTHERA PARDUS;

EID: 0030460794     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.1996.tb00111.x     Document Type: Article

References (12)

1. Abiose A, Jones BR, Consens SN et al (1993) Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis. Lancet 341, 130-134.
2. Alley ES, Plaisier AP, Boatin BA et al (1994) The impact of five years of annual ivermectin treatment on skin microfilarial loads in the onchocerciasis focus of Asubende, Ghana: Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 581-584.
3. Aziz MA, Diallo S, Diop IM, Larivière M & Porta M (1982) Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet ii, 171-173.
4. Chavasse DC, Whitworth JAG, Lemoh PA, Bennett S & Davies JB (1995) Low level ivermectin coverage and the transmission of onchocerciasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 534-537.
5. Dadzie KY, Remme J & De Sole G (1991) Changes in ocular onchocerciasis after two rounds of community-based ivermectin treatment in a holoendemic onchocerciasis focus. Transactions of the Royal Society of Tropical Medicine and Hygiene 85, 167-171.
6. Kläger S, Whitworth JAG, Post RJ, Chavasse DC & Downham MD (1993) How long do the effects of ivermectin on adult Onchocerca volvulus persist? Tropical Medicine and Parasitology 44, 305-310.
7. Kläger SL, Whitworth JAG & Downham MD (1996) Viability and fertility of adult Onchocerca volvulus after 6 years of treatment with ivermectin Tropical Medicine and International Health 1, 581-589.
8. Mabey D, Whitworth JA, Eckstein M, Gilbert C, Maude G & Downham M (1996) The effects of multiple doses of ivermectin on ocular onchocerciasis - a six-year follow-up. Ophthalmology 103, 1001-1008
9. Moyou Somo R, Ngosso A, Dinga JS et al (1993) A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitological findings after three treatments. American Journal of Tropical Medicine and Hygiene 48, 9-13.
10. Murdoch M, Hay RJ, Ramnarian N et al (1990) A clinical classification and grading system of the changes in onchocerciasis and histopathological findings. British Journal of Dermatology 123(Suppl. 37), 15.
11. Plaisier AP, Alley ES, Boatin BA et al (1995) Irreversible effects of ivermectin on adult parasites in onchocerciasis patients in the Onchocerciasis Control Programme in west Africa. Journal of Infectious Diseases 172, 204-210.
12. Taylor HR, Trpis M, Cupp EW et al (1988) Ivermectin prophylaxis against experimental Onchocerca volvulus infection in chimpanzees. American Journal of Tropical Medicine and Hygiene 39, 86-90.